Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-21

Clinical Trial Update: A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or Together [Phase 1]

View source ↗

Summary

Phase 1 study assessing how insulin icodec alone and with semaglutide behaves in the body of Chinese adults with type 2 diabetes, focusing on pharmacokinetics a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Icodec (insulin icodec)
  • semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED